Aberdeen Group plc

Position in ASND — Ascendis Pharma A/S

CIK 1716774 EDINBURGH, X0

Position in ASND

as of Mar 31, 2026 · filed Apr 29, 2026 Compact

Position Value

$48,068,523

+$798,121 QoQ

Shares Held

210,154

-5.2% QoQ

Ownership

0.320%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. ASND ranks #10 (2.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	233,480	$104,258,157
2	REGN	Regeneron Pharmaceuticals, Inc.	121,344	$93,755,226
3	IMUX	Immunic, Inc.	8,243,941	$91,507,745
4	QURE	uniQure N.V.	5,306,386	$86,759,411
5	MANE	Veradermics, Inc	1,054,660	$66,601,779
6	ARGX	Argenx SE	82,106	$59,957,906
7	PCVX	Vaxcyte, Inc.	978,969	$56,887,888
8	PRAX	Praxis Precision Medicines, Inc.	172,484	$55,572,619

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$48,068,523	210,154	-5.2%	Shares	Defined	2026-04-29
2025-12-31	$47,270,402	221,677	+348.5%	Shares	Defined	2026-01-16
2025-09-30	$9,826,383	49,426	-64.6%	Shares	Defined	2025-11-07
2025-06-30	$24,095,995	139,606	-18.7%	Shares	Defined	2025-07-24
2025-03-31	$26,765,993	171,731	-8.3%	Shares	Defined	2025-05-13
2024-12-31	$25,769,070	187,180	+18.3%	Shares	Defined	2025-01-24
2024-09-30	$23,622,783	158,213	-1.5%	Shares	Defined	2024-10-25
2024-06-30	$21,902,900	160,602	+15.7%	Shares	Defined	2024-08-09
2024-03-31	$20,981,035	138,791	0.0%	Shares	Defined	2024-05-09
2023-12-31	$17,480,726	138,791	—	Shares	Defined	2024-01-31
No filing history on record for this holder in this stock.